KEGG   Ochotona curzoniae (black-lipped pika): 121163235
Entry
121163235         CDS       T11174                                 
Symbol
MAP2K2
Name
(RefSeq) dual specificity mitogen-activated protein kinase kinase 2
  KO
K04369  mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
Organism
ocz  Ochotona curzoniae (black-lipped pika)
Pathway
ocz01521  EGFR tyrosine kinase inhibitor resistance
ocz01522  Endocrine resistance
ocz04010  MAPK signaling pathway
ocz04012  ErbB signaling pathway
ocz04014  Ras signaling pathway
ocz04015  Rap1 signaling pathway
ocz04022  cGMP-PKG signaling pathway
ocz04024  cAMP signaling pathway
ocz04066  HIF-1 signaling pathway
ocz04068  FoxO signaling pathway
ocz04071  Sphingolipid signaling pathway
ocz04072  Phospholipase D signaling pathway
ocz04140  Autophagy - animal
ocz04148  Efferocytosis
ocz04150  mTOR signaling pathway
ocz04151  PI3K-Akt signaling pathway
ocz04210  Apoptosis
ocz04218  Cellular senescence
ocz04270  Vascular smooth muscle contraction
ocz04370  VEGF signaling pathway
ocz04371  Apelin signaling pathway
ocz04517  IgSF CAM signaling
ocz04540  Gap junction
ocz04550  Signaling pathways regulating pluripotency of stem cells
ocz04613  Neutrophil extracellular trap formation
ocz04620  Toll-like receptor signaling pathway
ocz04650  Natural killer cell mediated cytotoxicity
ocz04660  T cell receptor signaling pathway
ocz04662  B cell receptor signaling pathway
ocz04664  Fc epsilon RI signaling pathway
ocz04720  Long-term potentiation
ocz04722  Neurotrophin signaling pathway
ocz04730  Long-term depression
ocz04810  Regulation of actin cytoskeleton
ocz04910  Insulin signaling pathway
ocz04912  GnRH signaling pathway
ocz04915  Estrogen signaling pathway
ocz04916  Melanogenesis
ocz04917  Prolactin signaling pathway
ocz04919  Thyroid hormone signaling pathway
ocz04921  Oxytocin signaling pathway
ocz04926  Relaxin signaling pathway
ocz04929  GnRH secretion
ocz04934  Cushing syndrome
ocz04935  Growth hormone synthesis, secretion and action
ocz05010  Alzheimer disease
ocz05022  Pathways of neurodegeneration - multiple diseases
ocz05132  Salmonella infection
ocz05135  Yersinia infection
ocz05160  Hepatitis C
ocz05161  Hepatitis B
ocz05163  Human cytomegalovirus infection
ocz05164  Influenza A
ocz05165  Human papillomavirus infection
ocz05166  Human T-cell leukemia virus 1 infection
ocz05167  Kaposi sarcoma-associated herpesvirus infection
ocz05170  Human immunodeficiency virus 1 infection
ocz05200  Pathways in cancer
ocz05205  Proteoglycans in cancer
ocz05206  MicroRNAs in cancer
ocz05207  Chemical carcinogenesis - receptor activation
ocz05208  Chemical carcinogenesis - reactive oxygen species
ocz05210  Colorectal cancer
ocz05211  Renal cell carcinoma
ocz05213  Endometrial cancer
ocz05214  Glioma
ocz05215  Prostate cancer
ocz05216  Thyroid cancer
ocz05218  Melanoma
ocz05219  Bladder cancer
ocz05220  Chronic myeloid leukemia
ocz05221  Acute myeloid leukemia
ocz05223  Non-small cell lung cancer
ocz05224  Breast cancer
ocz05225  Hepatocellular carcinoma
ocz05226  Gastric cancer
ocz05230  Central carbon metabolism in cancer
ocz05231  Choline metabolism in cancer
ocz05235  PD-L1 expression and PD-1 checkpoint pathway in cancer
Brite
KEGG Orthology (KO) [BR:ocz00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    121163235 (MAP2K2)
   04012 ErbB signaling pathway
    121163235 (MAP2K2)
   04014 Ras signaling pathway
    121163235 (MAP2K2)
   04015 Rap1 signaling pathway
    121163235 (MAP2K2)
   04370 VEGF signaling pathway
    121163235 (MAP2K2)
   04371 Apelin signaling pathway
    121163235 (MAP2K2)
   04066 HIF-1 signaling pathway
    121163235 (MAP2K2)
   04068 FoxO signaling pathway
    121163235 (MAP2K2)
   04072 Phospholipase D signaling pathway
    121163235 (MAP2K2)
   04071 Sphingolipid signaling pathway
    121163235 (MAP2K2)
   04024 cAMP signaling pathway
    121163235 (MAP2K2)
   04022 cGMP-PKG signaling pathway
    121163235 (MAP2K2)
   04151 PI3K-Akt signaling pathway
    121163235 (MAP2K2)
   04150 mTOR signaling pathway
    121163235 (MAP2K2)
  09133 Signaling molecules and interaction
   04517 IgSF CAM signaling
    121163235 (MAP2K2)
 09140 Cellular Processes
  09141 Transport and catabolism
   04140 Autophagy - animal
    121163235 (MAP2K2)
   04148 Efferocytosis
    121163235 (MAP2K2)
  09143 Cell growth and death
   04210 Apoptosis
    121163235 (MAP2K2)
   04218 Cellular senescence
    121163235 (MAP2K2)
  09144 Cellular community - eukaryotes
   04540 Gap junction
    121163235 (MAP2K2)
   04550 Signaling pathways regulating pluripotency of stem cells
    121163235 (MAP2K2)
  09142 Cell motility
   04810 Regulation of actin cytoskeleton
    121163235 (MAP2K2)
 09150 Organismal Systems
  09151 Immune system
   04613 Neutrophil extracellular trap formation
    121163235 (MAP2K2)
   04620 Toll-like receptor signaling pathway
    121163235 (MAP2K2)
   04650 Natural killer cell mediated cytotoxicity
    121163235 (MAP2K2)
   04660 T cell receptor signaling pathway
    121163235 (MAP2K2)
   04662 B cell receptor signaling pathway
    121163235 (MAP2K2)
   04664 Fc epsilon RI signaling pathway
    121163235 (MAP2K2)
  09152 Endocrine system
   04910 Insulin signaling pathway
    121163235 (MAP2K2)
   04929 GnRH secretion
    121163235 (MAP2K2)
   04912 GnRH signaling pathway
    121163235 (MAP2K2)
   04915 Estrogen signaling pathway
    121163235 (MAP2K2)
   04917 Prolactin signaling pathway
    121163235 (MAP2K2)
   04921 Oxytocin signaling pathway
    121163235 (MAP2K2)
   04926 Relaxin signaling pathway
    121163235 (MAP2K2)
   04935 Growth hormone synthesis, secretion and action
    121163235 (MAP2K2)
   04919 Thyroid hormone signaling pathway
    121163235 (MAP2K2)
   04916 Melanogenesis
    121163235 (MAP2K2)
  09153 Circulatory system
   04270 Vascular smooth muscle contraction
    121163235 (MAP2K2)
  09156 Nervous system
   04720 Long-term potentiation
    121163235 (MAP2K2)
   04730 Long-term depression
    121163235 (MAP2K2)
   04722 Neurotrophin signaling pathway
    121163235 (MAP2K2)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    121163235 (MAP2K2)
   05206 MicroRNAs in cancer
    121163235 (MAP2K2)
   05205 Proteoglycans in cancer
    121163235 (MAP2K2)
   05207 Chemical carcinogenesis - receptor activation
    121163235 (MAP2K2)
   05208 Chemical carcinogenesis - reactive oxygen species
    121163235 (MAP2K2)
   05230 Central carbon metabolism in cancer
    121163235 (MAP2K2)
   05231 Choline metabolism in cancer
    121163235 (MAP2K2)
   05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
    121163235 (MAP2K2)
  09162 Cancer: specific types
   05210 Colorectal cancer
    121163235 (MAP2K2)
   05225 Hepatocellular carcinoma
    121163235 (MAP2K2)
   05226 Gastric cancer
    121163235 (MAP2K2)
   05214 Glioma
    121163235 (MAP2K2)
   05216 Thyroid cancer
    121163235 (MAP2K2)
   05221 Acute myeloid leukemia
    121163235 (MAP2K2)
   05220 Chronic myeloid leukemia
    121163235 (MAP2K2)
   05218 Melanoma
    121163235 (MAP2K2)
   05211 Renal cell carcinoma
    121163235 (MAP2K2)
   05219 Bladder cancer
    121163235 (MAP2K2)
   05215 Prostate cancer
    121163235 (MAP2K2)
   05213 Endometrial cancer
    121163235 (MAP2K2)
   05224 Breast cancer
    121163235 (MAP2K2)
   05223 Non-small cell lung cancer
    121163235 (MAP2K2)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    121163235 (MAP2K2)
   05170 Human immunodeficiency virus 1 infection
    121163235 (MAP2K2)
   05161 Hepatitis B
    121163235 (MAP2K2)
   05160 Hepatitis C
    121163235 (MAP2K2)
   05164 Influenza A
    121163235 (MAP2K2)
   05163 Human cytomegalovirus infection
    121163235 (MAP2K2)
   05167 Kaposi sarcoma-associated herpesvirus infection
    121163235 (MAP2K2)
   05165 Human papillomavirus infection
    121163235 (MAP2K2)
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    121163235 (MAP2K2)
   05135 Yersinia infection
    121163235 (MAP2K2)
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    121163235 (MAP2K2)
   05022 Pathways of neurodegeneration - multiple diseases
    121163235 (MAP2K2)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    121163235 (MAP2K2)
  09176 Drug resistance: antineoplastic
   01521 EGFR tyrosine kinase inhibitor resistance
    121163235 (MAP2K2)
   01522 Endocrine resistance
    121163235 (MAP2K2)
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   01001 Protein kinases [BR:ocz01001]
    121163235 (MAP2K2)
Enzymes [BR:ocz01000]
 2. Transferases
  2.7  Transferring phosphorus-containing groups
   2.7.12  Dual-specificity kinases (those acting on Ser/Thr and Tyr residues)
    2.7.12.2  mitogen-activated protein kinase kinase
     121163235 (MAP2K2)
Protein kinases [BR:ocz01001]
 Serine/threonine kinases: STE group
  STE7 family
   121163235 (MAP2K2)
SSDB
Motif
Pfam: Pkinase PK_Tyr_Ser-Thr ABC1 Pkinase_fungal Kinase-like Haspin_kinase Kdo Seadorna_VP7 APH
Other DBs
NCBI-GeneID: 121163235
NCBI-ProteinID: XP_040846561
LinkDB
Position
Unknown
AA seq 400 aa
MLARRKPVLPALTINPTIAEGPSPISDGASEANLVDLHKKLEELELDEQQRRRLEAFLTQ
KAKVGELKDDDFERISELGAGNGGVVTKVRHRPSGLIMARKLIHLEIKPATRNQIIRELQ
VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAQRIPEEILGKVSIAVLRG
LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ
GTHYSVQSDIWSMGLSLVELAIGRYPVPPPDAKELEATFGRPVVDAADTEPHSTSPRPRP
PGRPASGHGVDSRPAMAIFELLDYIVNEPPPKLPSSVFTADFQEFVNKCLIKNPAERADL
KMLMNHAFIKRSEVEEVDFAGWLCETLRLKQPSTPTHSAV
NT seq 1203 nt   +upstreamnt  +downstreamnt
atgctggcccggaggaagccggtcctgccggcgctcaccatcaatcccaccatcgccgag
ggtccgtccccgatcagcgacggcgcgtccgaagcgaacctggtggacctgcacaagaag
cttgaggagcttgagttagacgagcagcagaggcgacgtctggaggccttcctcacgcag
aaggccaaggtcggcgagctcaaggacgatgactttgaaaggatctcggagctgggtgcc
ggcaatggcggcgtggtcaccaaggtgcggcacagaccctcagggcttatcatggccagg
aagctgatccacctggagatcaagccggccacccggaaccaaatcatccgtgagctgcag
gtgctgcacgagtgcaactcgccctacatcgtgggcttctacggggccttctacagcgac
ggcgagatcagtatatgcatggagcacatggatggcggctccctggaccaggtgctgaag
gaggcccagaggattccagaagagatcctgggtaaagtcagcattgcggtcctccggggt
ctggcgtatctccgagagaaacaccaaatcatgcatcgagacgtgaagccctccaacatt
ctggtcaactcccgcggcgagattaagctgtgcgactttggcgtcagcgggcagctcatc
gactccatggccaactccttcgtgggcacgcgttcctacatgtctccggagcggctgcag
ggcacccactactcggtgcagtcggatatctggagcatgggcctgtccctggtggagctg
gccatcggcaggtacccggtccccccgccggacgccaaggagctcgaggccacgttcggc
cggcccgtggtggacgcggcggacacagagcctcacagcacctcaccgcgcccacggccc
ccgggacgccccgccagcggtcacggggtggacagccggccagccatggccatctttgaa
ctactggactacattgtgaatgagccacctcccaagctgcccagcagcgtgttcaccgcc
gacttccaggagtttgtaaataaatgcctcatcaagaaccctgcggaacgagcagacctc
aagatgctcatgaaccacgccttcatcaagcggtccgaggtagaggaagtggactttgct
ggctggctctgcgagaccctgcggctgaagcaacccagcacgcccacgcactcggccgtg
tga

DBGET integrated database retrieval system